Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carotid Atherosclerotic Plaque With Inflammation”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT00352417
What this trial is testing

Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy

Who this might be right for
Atherosclerosis
Tallikut Pharmaceuticals, Inc. 50
Post-approval studies (Phase 4)Study completedNCT04056169
What this trial is testing

Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeCarotid Atherosclerotic Plaque With Inflammation
Yuhan Corporation 50
Post-approval studies (Phase 4)Study completedNCT05797376
What this trial is testing

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation

Who this might be right for
Atherosclerosis of ArteryCoronary Artery DiseasePeripheral Arterial Disease+1 more
Asan Medical Center 92
Not applicableWithdrawnNCT00388843
What this trial is testing

Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)

Who this might be right for
Carotid Atherosclerosis
Medical College of Wisconsin
Testing effectiveness (Phase 2)UnknownNCT01601106
What this trial is testing

Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic Disease

Who this might be right for
AtherosclerosisInflammation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30